fda update tirzepatide says the weight-loss drug shortage is over FDA Approves Tirzepatide, A Potential

This plaque can narrow and harden the arteries, leading to a condition called atherosclerosis, which increases the risk of heart attack and stroke

In people who have a body mass index of over 35, some of the best solutions that keep the weight off for a few years, studies show, are bariatric surgery (an operation that makes your stomach smaller and so helps you to eat less) or appetite-suppressing medicines such as Ozempic

Most researchers report no noticeable potency issues at the 5-week mark, but conservative protocols suggest using the vial within 4 weeks and discarding any remainder

It is important that people who are prescribed GLP-1 analogues continue to take them and contact their diabetes team if they have any concerns. References [1] US Food and Drug Adminstration